{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-26-001326","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.954572+00:00","generated_at":"2026-05-15T19:03:03.850594+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Medicus Pharma sells 4.47M shares for $3.85M under Yorkville SEPA through Mar 6, 2026","bullets":["Total of 4,471,038 common shares sold under SEPA from Dec 2025 to Mar 2026 for aggregate $3,846,910.","Largest single draw: 1,425,000 shares on Mar 6, 2026 for approx $640,110.","Proceeds used partly to prepay outstanding debenture with Yorkville (previously disclosed in Sep 2025 8-K).","Yorkville may resell shares under an effective registration statement; additional draws possible subject to SEPA conditions.","Sales rely on Section 4(a)(2) exemption; Yorkville represented itself as an accredited investor."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-001326","json":"https://secwatch.observer/filing/0001062993-26-001326.json","markdown":"https://secwatch.observer/filing/0001062993-26-001326.md","text":"https://secwatch.observer/filing/0001062993-26-001326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/0001062993-26-001326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T19:03:03.850594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e2669d288c7a66c023995a67303337ceeca6ab73","claim":"Medicus Pharma Ltd. issued 4,471,038 of common stock to YA II PN, Ltd. for $3,846,910.","evidence_excerpt":"the Company completed sales of its common shares (the \"Common Shares\") to Yorkville (collectively, the \"SEPA Advances\") as disclosed in the table below: Date of Sale Number of Common Shares Approximate Aggregate Consideration December 19, 2025 66,667 $113,647 December 19, 2025 5,432 $9,221 December 29, 2025 41,250 $66,149 December 29, 2025 20,909 $32,451 January 9, 2026 100,000 $150,640 January 15, 2026 33,333 $48,006 January 15, 2026 11,347 $15,960 January 29, 2026 7,100 $8,609 February 10, 2026 175,000 $186,603 February 18, 2026 250,000 $237,200 February 23, 2026 275,000 $302,088 March 5, 2026 700,000 $988,890 March 5, 2026 1,360,000 $1,047,336 March 6, 2026 1,425,000 $640,110 Total 4,471,038 $3,846,910","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/0001062993-26-001326-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"4,471,038"},{"label":"Purchaser","value":"YA II PN, Ltd."},{"label":"Consideration","value":"$3,846,910"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}